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ABSTRACT
Objective: The recent work was carried out to evaluate the presence of bioactive compounds and anticancer activities of selected plant Trigonella 
foenum-graecum extract.
Methods: The crude extraction of whole plant was carried out using petroleum ether as a solvent by cold percolation as well as hot percolation 
method (Soxhlet method) both. The presence of phytochemicals was determined using standard protocols. The anticancer activities were evaluated 
by sulforhodamine B (SRB) dye assay method using Mitomycin-C (anticancer drug) as a positive control.
Results: The qualitative analysis of plant extract showed the presence of bioactive compounds, namely, protein, alkaloids, steroids, phenolics, and 
flavonoids. The plant extract was tested for in vitro anticancer activity against human liver cancer (HEP-2) and colon cancer (HT-29) cell lines using 
SRB assay. The plant extract showed significant results against HT-29 and HEP-2 cancer cell lines.
Conclusion: The study concluded that the extract of T. foenum-graecum can be further carefully used in herbal formulations for cancer therapy.
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INTRODUCTION
Cancer is a heterogeneous group of diseases that affect people at all 
ages and can spread to surrounding tissues. The American Cancer 
Society reported that the deaths due to cancer constitute 2–3% of the 
annual deaths worldwide. Normally, the balance between cell division 
and cell death is tightly regulated, but disturbances in this process 
cause either a benign or a malignant tumor [1]. The study of research 
papers/articles clearly indicated that herbal medicine exhibits a 
variety of therapeutic properties and provides more health security 
to the people in primary health care [2-5]. According to the WHO, 
about more than 80% of the human population relies on Ayurvedic 
medicines for their primary health care [6]. The past review literature 
showed that various parts of the plant were used in Ayurveda, 
Unani, and Siddha for the treatment of various kinds of human 
and animal diseases [7]. In the area of herbal treatment, Trigonella 
foenum-graecum L. have rich source of proteins, phenolics, alkaloids, 
flavonoids, steroids, etc., that have a potential to the treatment in 
various types of diseases including cancer [8]. Herbal plants are being 
used traditionally for the treatment of various kinds of illness [9]. In 
recent time, there is a great emphasis which has been given toward 
herbal research on complementary and alternative medicine that 
deals with the treatment and cure of cancer [10]. The medicinal 
plants have a diverse group of highly valuable and readily available 
source of bioactive organic compounds, for example, alkaloids, 
tannins, essential oils, proteins, and flavonoids [11-13] which have 
been used in medicinal practices for a long time [14]. The anticancer 
activity of the plant Tectaria cicutaria extract was tested in vitro 
using sulforhodamine B (SRB) assay against some cancer cell lines, 
namely, human leukemia cell line (K-562), human nasopharyngeal cell 
line (KB), human colon cell line (HT-29), and human colon cell line 
(COLO-205) that showed significant results [15].
T. foenum-graecum L. is an annual herb crop commonly known as 
fenugreek which belongs to Family Fabaceae. The fenugreek seeds are 
widely used in South Asia for lowering the blood sugar level, fatty acids, 
and cholesterol levels. Hence, it is used in the prevention/treatment of 
diabetes and coronary heart diseases [16]. In ancient Rome, the roots 
of T. foenum-graecum were used to aid labor and delivery. In traditional 
Chinese system of medicine, T. foenum-graecum seeds were used as 
a tonic as well as the treatment for weakness and edema of legs [17]. 
T. foenum-graecum extract composed of proteins, polysaccharides, oils, 
fibers, flavonoids, saponins, trigonelline, and choline [18].
Keeping the above review literature in mind, our research work was, 
therefore, planned to evaluate the presence of bioactive compounds and 
anticancer potential of T. foenum-graecum extract using two selected 
human cancer cell lines, namely, liver cancer cell line (HEP-2) and colon 
cancer cell line (HT-29).
METHODS
Collection of plant material, authentication, and preparation of 
plant extract
The plants were collected and authenticated from Botanical Survey of 
India (BSI), Dehradun, U.K., India. According to BSI, the botanical name 
of selected plant is T. foenum-graecum L. which belongs to the family 
Fabaceae with accession no. 114535. The whole plants were washed 
with tap water and dried at room temperature in the laboratory and then 
little grinded. The extract was obtained by cold percolation as well as hot 
percolation (Soxhlet) method, using petroleum ether as a solvent. Extract 
was fine filtered, dried, and frozen at 8°C. During experiment, the extract 
was redissolved in dimethyl sulfoxide (DMSO) to form stock solutions, 
which were filtering sterilized (0.2 μm) before testing the experiments.
Protocol for preliminary qualitative screening of bioactive 
compounds
The biochemical tests for the determination of bioactive compounds 
have been done using standard protocols. For each of the test, 100 µg/ml 
concentration of the extract was used [19].
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Test for protein
One milliliter extract solution was treated with few drops of 
concentrated nitric acid, the formation of yellow color indicates the 
presence of proteins.
Test for alkaloids
Extract was dissolved individually in dilute HCl and filter with filter 
paper, then filtrate was treated with saturated picric acids solution 
resulting in the formation of light brown precipitate which indicates 
the presence of alkaloids.
Test for steroids
One milliliter extract mixed with 2 ml of chloroform then carefully 




One hundred microliters extract solution was treated with few drops of 
sodium hydroxide solution, then the formation of yellow color was the 
result which becomes colorless on addition of dilute HCl acid indicates 
the presence of flavonoids.
Lead acetate test
To 1.0 ml of plant extract solution very carefully add freshly prepared 
few drops of lead acetate solution. The formation of light yellow 
precipitate indicated the presence of flavonoids.
Test for phenols
One hundred microliters extract solution was mixed with 2 ml of 2% 
solution of FeCl3. Blue/green color result indicated the presence of 
phenols.
Test for tannins
One hundred microliters extract solution was mixed with 2 ml of 2% 
solution of FeCl3. Black color indicated the presence of tannins.
Test for terpenoids
One hundred microliters extract solution was mixed with 2 ml of 
chloroform, then very carefully add 2 ml of conc. H2SO4 acid and shaken 
by rotating the test tube gently. The color of solution changed into 
reddish-brown that indicated the presence of terpenoid compounds.
Study of anticancer potential assay from extract
Sources of cancer cell lines
Cancer cell lines were obtained from the National Centre for Cell Sciences, 
Ganeshkhind, Pune, 411007 (India), for the recent experiments.
Human cancer cell lines
The selected human cancer cell lines such as liver cancer (Hep-2) 
and colon cancer (HT-29) were grown in RPMI-1640 media with 
2 mM L-glutamine medium (pH 7.2). Penicillin tablet (antibiotics) 
was dissolved in PBS and sterilized by filtering through 0.2 μ cellulose 
filter paper in laminar airflow hood. The growth media were stored 
at low temperature (nearly 4°C). The whole complete growth media 
contained 10% fetal calf serum (FCS). The growth medium used 
for cryopreservation contained 20% FCS and 10% DMSO in growth 
medium. The cancer cell lines (Hep-2 and HT-29) were maintained at 
37°C in atmosphere containing 5% CO2 and 90% humidity [20].
In vitro study of anticancer potential
The anticancer activity was determined by evaluating the cytotoxic 
potential of the test material using human cancer cell lines such as 
HEP-2 and HT-29, these test materials were allowed to grow on tissue 
culture plates in the presence of desired test material. The cell growth 
was determined using ELISA reader after staining with SRB dye which 
binds to basic amino acid residues in the trichloroacetic acid (TCA) 
fixed cells.
Preparation of cell suspension for assay
Human cancer cell lines (HEP-2 and HT-29) were grown in multiple 
tissue culture flasks (TCFs) at 37°C in the atmosphere of 5% CO2 and 
90% relative humidity in the presence of complete growth medium 
to obtain enough number of cancerous cells. The TCFs with cells at 
subconfluent growth stage were selected for the experiment. The 
fully grown cancer cells were carefully harvested after treatment with 
trypsin-ethylenediaminetetraacetic acid solution and then separated to 
single cell by smooth pipetting. Thereafter, viable cells were counted 
using Trypan blue dye with the help of hemocytometer. The cancer 
cell viability at this stage was found more than 97%. Viable cancer 
cell density was maintained and adjusted to 5000–40,000 cells/100 μl 
depending on the type of cell line. Cell suspension (100 μl) together 
with 100 μl of complete growth medium was added into each 96-well 
plate. The 96-well plates were kept in CO2 incubator at 37°C for 24 h in 
an atmosphere of 5% CO2 and 90% relative humidity inside. After 24 h, 
the test material, DMSO (vehicle control), and positive control were 
added [21].
SRB assay
The antiproliferative SRB assay was performed to assess growth 
inhibition. It is a colorimetric method assay which estimates the total 
cell number indirectly by staining cellular active proteins by SRB 
dye [22]. The microtiter tissue culture plates were removed out after 
48 h incubation of the cells with test materials and gently layered with 
ice-cold 50% TCA in entire wells; then, 96-well tissue culture plate was 
incubated at 4°C for up to 1 h. After 1 h incubation, all cells were attached 
to the bottom and supernatant was discarded by simple pipetting. The 
cell plates were washed many times with double-distilled water to 
remove extra TCA, growth medium, low-molecular-weight metabolites, 
serum proteins, and other unwanted materials. After removing the 
tissue culture plate, it dried in air and then SRB solution was added 
very carefully into each well and then incubated about ½ h at room 
temperature. The unbound SRB solution was removed by washing all 
the wells of tissue culture plate with 1% solution of acetic acid and air 
dried. When the wells were dried, then 100 µl Tris buffer of pH 10.4 was 
added. The whole contents were mixed using mechanical shaker. After 
removing from mechanical shaker, the optical density (absorbancy) 
was measured on ELISA reader at 515 nm [23].
Positive control
The positive control used was Mitomycin-C (anticancer medicine).
Calculation: Cell viability and growth in the presence of test material 
were calculated as follows: Percentage cell growth in the presence of 
test material:
=(Cell growth in presence of test material/Cell growth in absence of test 
material)×100.
Percentage cell growth inhibition in the presence of test material was 
determined as follows:
=100 ─ percentage cell growth in presence of test material.
Criteria for the determination of activity
The test sample showing growth inhibition of ≥70% when solution 
concentration is 100 µg/ml, then it considered to be active.
Statistical analysis
The experimental result was obtained as the mean ± S.D. Differences 
were considered statistically significant when P ≤ 0.05. Statistical 
calculations were carried out using Microsoft Excel 2010.
RESULTS
Qualitative screening of bioactive compounds
The quantitative biochemical tests from petroleum ether extract 
of T. foenum-graecum showed the presence of proteins, phenolics, 
alkaloids, flavonoids, and steroids (Table 1).
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Result of in vitro anticancer activity
The anticancer activities of plant extract are summarized in Table 2.
If the test sample shows growth inhibition ≥70% at 100 µg/ml solution, 
then it is considered a significant result. The total experimental data 
were summarized in tabular form (Table 2) and graphs were plotted, 
as shown in Fig. 1 and 2. In vitro cytotoxicity of plant extract was 
determined against human liver cancer cell line (HEP-2) which showed 
82%, 80%, and 72% growth inhibition of the sample number – UTU 4, 
UTU 10, and UTU 16, respectively, while Mitomycin-C (positive control) 
showed 82% growth inhibition, whereas in case of colon cancer cell 
line (HT-29) showed 77%, 78%, 78%, and 78% growth of inhibition of 
the sample number – UTU 9, UTU 11, UTU 16, and UTU 17, respectively, 
while Mitomycin-C (positive control) showed 80% growth inhibition. 
The mean values of all data showed 78% growth inhibition against 
HEP-2 cell lines while 77.75% growth inhibition against HT-29 cell 
lines [15].
DISCUSSION
The qualitative test results showed that T. foenum-graecum extract 
contains bioactive compounds, namely, proteins, phenolics, 
alkaloids, flavonoids, and steroids [18]. The anticancer potential was 
determined by the cytotoxic potential of the test material using liver 
and colon cancer cell lines (HEP-2 and HT-29), which were grown on 
tissue culture plates in the presence of test material. The cell growth 
is measured on ELISA reader after staining with SRB dye that binds 
to basic amino acid residues in trichloroacetic acid fixed cells. Table 1 
shows that the T. foenum-graecum L. have rich source of bioactive 
organic compounds such as proteins, phenolics, alkaloids, flavonoids, 
and steroids that possess unique medicinal activities. Therefore, 
plant containing these bioactive organic compounds may serve as 
a potential source in the treatment of colon and liver cancers. The 
possible cause of cancer activity is due to the free radical formation. 
Hence, plants containing phenolics, alkaloids, flavonoids, steroids, etc., 
are constantly being screened for anticancer activity (Fig. 1 and 2). 
Some of the active compounds present in this plant are reported to 
be antioxidant. The activity of compounds should be depended more 
likely to the type and concentration of cancer cell lines [8]. Denny and 
Wansbrough [10] reported that the major challenge is to design new 
drugs that will be more effective for the treatment of cancerous cells 
and have lesser side effect. Many plant extracts kill and reduce the 
growth of cancerous cell through activating apoptosis and affecting 
growth regulators.
However, on the basis review/research articles study, it is revealed that 
flavonoids, alkaloids, phenolics, tannins, etc., seem to be most likely 




































Fig. 2: Percentage of growth inhibition on HT-29 cell line
Table 1: Qualitative biochemical tests result of plant extract
Compounds→ Protein Alkaloids Steroids Phenolics Flavonoids
Present (+)→ + + + + +
Table 2: Percentage of cancer cell growth inhibition by plant extract
Tissues→ Liver cancer cell line Colon cancer cell line
NCFT code Inst. code Conc. (µg/ml) Hep-2 HT-29
NCFT-863 UTU-4 100 82 28
NCFT-868 UTU-9 100 34 77
NCFT-869 UTU-10 100 80 68
NCFT-870 UTU-11 100 65 78
NCFT-875 UTU-16 100 72 78
NCFT-876 UTU-17 100 08 78
Mitomycin-C 1×10−6 M 82 80
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CONCLUSION
The recent work authenticated the T. foenum-graecum plant contains 
bioactive compounds that have a potential to reduce cancer cell 
growth in vitro by different inhibitory pathways. Many plant extracts 
destroy cancer cells through activating apoptosis and effecting growth 
regulators. The research work was very interesting to study the 
anticancer potential, biochemically identification of compounds, and 
mechanism of action of the phytoconstituents.
Finally, it can be concluded that the phytoconstituents of this plant can 
be further used in herbal formulation in pharmaceutics.
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